ALS Archives - DelveInsight

ALS

Clover gets fund; Libtayo for first-line Advanced NSCLC Subset
Clover biopharmaceuticals raises $230 M; BrainStorm after ALS; BARDA grants $5.65 M LightDeck for...

Clover Biopharmaceuticals Raises $230 Million Clover Biopharmaceuticals announced the completion of an oversubscribed $230 million Series C financing, summing total capital raised by the ...


Oncology
Notizia

Stopping breast cancer metastasis by killing tumor cells in their sleepOncology researchers believed that dormant breast cancer cells are not responsive to chemotherapy. But these inactive can...


KEY CLINICAL OUTCOMES

Streamlined solutions provided by Cognitive Clinical Trials (CCT) related to the treatment and prevention of Alzheimer’s diseaseCongnitive Clinical Trials (CCT) has introduced a new research mode...


Thrombolytic Sciences’ trial; NurOwn for ALS; Biosimilar receives approval; Trelegy Ellipta for t...

Thrombolytic Sciences announced completion of Phase I TS01 trial A clinical stage vascular health and biotech company, Thrombolytic Science, LLC (TSI), announced the completion of its Phase I trial...


Amyotrophic Lateral Sclerosis (ALS) a fatal disease!

Amyotrophic Lateral Sclerosis (ALS) also known as Lou Gehrig’s disease is a progressive, rarely occurring neurological disease that mainly involves the nerve cells (neurons) which are responsible f...


Denali’s Impressive Research Portfolio

The South San Francisco biotech startup, Denali Therapeutics, that had raised $217 million last year to fight Alzheimer’s, Parkinson’s and ALS, and an additional  $130 million from investors in a p...


Editor's Pick
An in-depth Assessment of the Top Drugs Launched by Leading Global Companies ...

Progress is driven by innovation. When it comes to developing novel medications and the...

Changing Dynamics of HIV-1 Treatment Market

The HIV-1 treatment market for naïve and experienced patients is evolving consistently....

Which Countries Top the Chart in Global Pharmaceutical Market?

The Pharmaceuticals segment of the Healthcare Industry has a significant market across ...

von Willebrand disease (VWD) – Misdiagnosis Still Prevalent!

Von Willebrand disease is a type of blood disorder that causes the blood to clot improp...

Analyzing the Key Companies and the Emerging Gene Therapy in the Dermatology ...

Advances in genetics research have sparked a surge in interest in gene therapy in derma...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.